[1]
Siragusa, S. 2011. Low molecular weight heparins in cancer patients: to treat thromboembolic events, the tumor, or both?. Oncology Reviews. 1, 1 (Dec. 2011), 36-44. DOI:https://doi.org/10.4081/oncol.2007.138.